Meeting
2024 ASCO Genitourinary Cancers Symposium
IL-6 and PIM1 expression in renal cell carcinoma.
Authors
Kimberly Stephanie Meza
Brown University, Providence, RI
Kimberly Stephanie Meza , Kimberly Seymour , Stephanie L. Graff , Chadi Nabhan , Andrew Elliott , Sheldon L. Holder
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 470)
DOI
10.1200/JCO.2024.42.4_suppl.470
Abstract #
470
Poster Bd #
K11
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Targeting an IL-6/JAK/STAT/PIM1 pathway in renal cell carcinoma.
First Author: Kimberly Stephanie Meza
Poster
2014 ASCO Annual Meeting
Prognostic and predictive tumor-based biomarkers in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (IFN) with or without bevacizumab (Bev): Results from CALGB (Alliance) 90206.
First Author: Harriet M. Kluger
Poster
2019 Gastrointestinal Cancers Symposium
The effect of hepatic stellate cells on hepatocellular carcinoma progression.
First Author: Shuichi Iwahashi
Poster
2014 ASCO Annual Meeting
Reverse phase protein microarray for identification of IL6 receptor ligation-induced insulin receptor, PI3K/AKT, and JAK/STAT signaling pathways in the CARD11 mutated lymphoma cell line OCI-Ly3.
First Author: Greg Coffey